Neurocognitive performance and negative symptoms: Are they equal in explaining disability in schizophrenia outpatients?

被引:65
|
作者
Villalta-Gil, Victoria
Vilaplana, Miriam
Ochoa, Susana
Haro, Josep Maria
Dolz, Montserrat
Usall, Judit
Cervilla, Jorge
机构
[1] St Joan Deu Serv Salud Mental, Fundac St Joan Deu, Res & Dev Unit, Barcelona 08830, Spain
[2] Univ Granada, Inst Neurosci, Granada, Spain
关键词
schizophrenia; psychopathology; Positive and Negative Syndrome Scale (PANSS); cognitive functioning; disability;
D O I
10.1016/j.schres.2006.06.013
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The aim of this study is to assess if cognitive variables and symptom dimensions can predict disability in a sample of outpatients with schizophrenia. Method: A cross-sectional sample of 113 individuals with a diagnosis of schizophrenia (DSM-IV criteria) was selected from a computerized register of five Community Mental Health Centers. Patients were assessed by two trained psychologists, with a neuropsychological battery comprising measures for verbal memory, attention, operative memory and abstraction and flexibility functions. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS); a socio-demographic and clinical questionnaire, comprising the Disability Assessment Scale (DAS), was also completed. Test scores were standardized (t scores) to performance of healthy controls. To assess the relationship between clinical and sociodemographic factors and disability and cognitive functioning Pearson's correlation coefficients were computed. In order to establish the predictive capacity of the cognitive, clinical and symptom variables on disability linear regression models were fitted. Results: Mean age of patients was 41.6 years and 68% were male. Higher ratings in the negative dimension were associated with more cognitive deficits. Association with the positive dimension was present but less strong. All disability areas, except for disability in occupational functioning, were partially explained by the negative dimension. Disability in family functioning was also partially explained by attention and number of admissions since onset. Conclusion: Negative symptoms are the major source of disability of our sample and are also associated to cognitive functioning. The present findings suggest that further investigation on the mediators between clinical and social outcomes may help to design specific treatments to reduce disability. (c) 2006 Elsevier B.V All rights reserved.
引用
收藏
页码:246 / 253
页数:8
相关论文
共 50 条
  • [1] Understanding disability in schizophrenia: The role of gender, negative symptoms and neurocognitive deficits
    Jaeger, J
    Berns, S
    Czobor, P
    Ast, MA
    Gomes, C
    Donovan-Lepore, A
    Abdelmessih, S
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 110 - 110
  • [2] Does Integrated Neurocognitive Therapy (INT) reduce severe negative symptoms in schizophrenia outpatients?
    Mueller, Daniel R.
    Khalesi, Zahra
    Benzing, Valentin
    Castiglione, Clelia I.
    Roder, Volker
    [J]. SCHIZOPHRENIA RESEARCH, 2017, 188 : 92 - 97
  • [3] Neurocognitive changes and negative symptoms in schizophrenia
    Thoma, P
    Daum, I
    [J]. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2005, 73 (06) : 333 - 342
  • [4] The influence of neurocognitive deficits and symptoms on disability in schizophrenia
    Ertugrul, A
    Ulug, B
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2002, 105 (03) : 196 - 201
  • [5] Symptoms of schizophrenia and neurocognitive test performance
    Shean, G
    Burnett, T
    Eckman, FS
    [J]. JOURNAL OF CLINICAL PSYCHOLOGY, 2002, 58 (07) : 723 - 731
  • [6] Neuropsychological performance and cognitive disability in schizophrenia outpatients
    Bobes, J.
    Garcia-Portilla, M. P.
    Fillat, O.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S445 - S446
  • [7] ERP correlates of neurocognitive impairment and negative symptoms in schizophrenia
    Mucci, A.
    Giordano, G. M.
    Perrottelli, A.
    Caporusso, E.
    Giuliani, L.
    Pezzella, P.
    [J]. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 2023, 188 : 48 - 48
  • [8] EFFECTS OF CLOZAPINE ON POSITIVE AND NEGATIVE SYMPTOMS IN OUTPATIENTS WITH SCHIZOPHRENIA
    BREIER, A
    BUCHANAN, RW
    KIRKPATRICK, B
    DAVIS, OR
    IRISH, D
    SUMMERFELT, A
    CARPENTER, WT
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1994, 151 (01): : 20 - 26
  • [9] Lexical Diversity and Other Linguistic Measures in Schizophrenia Associations With Negative Symptoms and Neurocognitive Performance
    Compton, Michael T. T.
    Ku, Benson S. S.
    Covington, Michael A. A.
    Metzger, Celia
    Hogoboom, Anya
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2023, 211 (08) : 613 - 620
  • [10] Do needs, symptoms or disability of outpatients with schizophrenia influence family burden?
    Ochoa, Susana
    Vilaplana, Miriam
    Maria Haro, Josep
    Villalta-Gil, Victoria
    Martinez, Francisco
    Cruz Negredo, Mari
    Casacuberta, Pilar
    Paniego, Elena
    Usall, Judith
    Dolz, Montserrat
    Autonell, Jaume
    [J]. SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2008, 43 (08) : 612 - 618